Stay informed with the latest litigation news. Explore now

Ganymed Pharmaceuticals competitive analysis

Latest publications and patents of Ganymed Pharmaceuticals New

Explore the latest publications and patents granted to Ganymed Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 8, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ganymed Pharmaceuticals

Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell EpitopesPatent Maintained As Amended
Sep 9, 2020Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of CancerGranted And Under Opposition
Jan 17, 2018Monoclonal Antibodies For Treatment Of CancerNo Opposition Filed Within Time Limit
Jan 3, 2018Identification Of Tumor-Associated Antigens For Diagnosis And TherapyNo Opposition Filed Within Time Limit
Jan 3, 2018Identification Of Tumour-Associated Cell Surface Antigens For Diagnosis And TherapyNo Opposition Filed Within Time Limit
Jan 3, 2018Identification Of Tumour-Associated Cell Surface Antigens For Diagnosis And TherapyNo Opposition Filed Within Time Limit

Explore Ganymed Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 11, 2025
Patent NumberGrant DateTitleTotal Oppositions
Feb 16, 2022Claudin-6-Specific Immunoreceptors And T Cell Epitopes1
Sep 9, 2020Combination Therapy Involving Antibodies Against Claudin 18.2 For Treatment Of Cancer1

Latest PTAB cases involving Ganymed Pharmaceuticals New

Discover the latest PTAB cases involving Ganymed Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Top competitors of Ganymed Pharmaceuticals

Top competitors of Ganymed Pharmaceuticals based on patent oppositions.